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subfamily use the amino acid sequence 
Arg-Gly-Asp (RGD) as a minimal essen-
tial binding motif. [ 4 ] Several proteins of the 
ECM contain this tripeptidic motif, vitron-
ectin (Vn) being one of the most prominent 
ones. [ 2a , 5 ] The integrin subtype  α v β 3, which 
primarily binds to Vn, plays a pivotal role 
for initial cell adhesion. [ 6 ] As cell adhesion 
is crucial in several physiological processes 
and important in the development of dis-
eases like thrombosis (blood coagulation), 
osteoporosis (insuffi cient bone matrix 
remodeling), and cancer (angiogenesis and 
vascularization), this class of proteins has 
attracted much attention. [ 2b , 7 ] 
 Starting from the linear RGD sequence, 
our group has applied several techniques 
to restrict the conformational space such 
as cyclization, [ 8 ] incorporation of a  d -amino 
acid [ 9 ] and N-methylation, [ 10 ] leading to the 
development of the anti-angiogenic drug 
 c (-RGDf( N -Me)Val-), also known as Cilengit
ide. [ 10a , 10d ] Cilengitide is currently in clinical 
phase II for treatment of several cancers. Additionally, targeting 
of integrins by means of  c RGD-based compounds has promoted 
tremendous advances in the biomaterials fi eld and its use for 
biomedical applications has increased dramatically in the last 
decade. [ 7d ] Examples for applications include the use of  c RGD pep-
tides for the development of integrin  α v β 3-targeted radiotracers [ 11 ] 
to image metastatic tumors, [ 12 ] as coatings for titanium implants 
or organic materials to enhance bone healing, [ 13 ] and for surface-
modifi cation of liposomes for site selective vascular delivery. [ 14 ] 
In all these cases, the successful development of the scaffolds for 
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 1 .  Introduction 
 Cell adhesion is a fundamental process for multicellular organ-
isms, whereas integrins are one of the most important protein 
families mediating this event. [ 1 ] These transmembrane spanning 
glycoproteins consist of an  α - and  β -subunit [ 2 ] and mediate cell 
adhesion by connecting the cytoskeleton to proteins of the extra-
cellular matrix (ECM). So far 24 different heterodimeric inte-
grins, which can be classifi ed into four subfamilies, have been 
identifi ed. [ 2,3 ] The members of the RGD recognizing integrin 
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allows the precise positioning of gold nanoparticles (AuNPs) in 
a quasi hexagonal pattern with a tunable horizontal interparticle 
distance. [ 19 ] Functionalization of the AuNPs with a cyclic adhe-
sive peptide, such as  c (-RGDfK-), has allowed a number of inves-
tigations on integrin-mediated cell adhesion under a wide variety 
of specifi c geometrical arrays. [ 20 ] In these studies, it was shown 
that an interparticle distance of less than 70 nm is suffi cient to 
allow for stable cell adhesion, which is characterized by the devel-
opment of mature focal adhesion (FA) points. [ 20a ] 
 It is well known that polyproline forms an extended helix of 
type II (PPII) in aqueous media (see e.g., another study [ 21 ] and 
references cited therein). Within this helix, three proline resi-
dues construct a full turn of the helix and the fourth residue 
(i+3) is precisely above the fi rst. Three prolines elongate the helix 
by about 9.3 Å. This helical feature of the polyproline sequence 
has been widely used as ruler for ligand presentation. [ 22 ] 
 Here, we systematically compare the infl uence of different 
spacer systems on the binding affi nity of a  c (-RGDfX-)-con-
taining ligand to its primary target, integrin  α v β 3. The ligands 
were modifi ed with three kinds of spacers: aminohexanoic 
acid (Ahx), PEG-based spacers, and polyproline sequences, the 
former two being examples of fl exible spacers, the latter an 
example of a more rigid spacer. In addition, we investigated 
the effect of dimerization of the polyproline-based spacers 
( Figure  1 ) on the affi nity to integrin  α v β 3. All synthesized pep-
tides were tested in vitro in a competitive ELISA assay using 
the natural ligand, Vn, and the soluble integrin  α v β 3. [ 23 ] These 
assays showed that  c RGD bearing polyproline-based spacers 
displayed signifi cantly higher integrin  α v β 3 binding affi nity 
than those bearing fl exible spacers. To address the effect of the 
integrin adhesion relied on understanding the regulatory interac-
tions between cells and the coating components. Hence, optimi-
zation is of utmost importance for many applications. 
 Synthetic ligands used for integrin attachment to surfaces 
are modular in structure and contain three typical elements: an 
integrin-binding head group, a spacer component of variable 
length and fl exibility, and an attachment point for anchorage 
(e.g., a thiol group for binding to gold). The non  N -methylated 
stem peptide  c (-RGDfV-) [ 8 ] constitutes a commonly used head 
group. Regarding its sequence, it was shown that the 5th posi-
tion (valine) in this sequence can be substituted by any other 
amino acid without affecting the activity of the peptide. [ 15 ] As 
a consequence, many studies used head groups consisting of 
 c (-RGDfK-),  c (-RGDfE-), or a corresponding derivative to the 
side chain of lysine or glutamic acid in conjunction with ali-
phatic, or polyethylene glycol (PEG)-based spacers. [ 13a , 16 ] Unfor-
tunately, the introduction of side chain modifi cations reduced 
the binding affi nity of the ligands to integrins. To retain binding 
affi nity, polyvalent ligands possessing two or more binding 
motifs were designed. [ 11c , 17 ] However, those multivalent peptides 
are bigger in size and the positive effect of multivalency is par-
tially compensated. [ 17a ] A distinctive feature of aliphatic and PEG 
spacers is their high fl exibility. The preferred conformation in 
PEG is a gauche arrangement and not the fully extended trans. [ 18 ] 
Hence, it is impossible to precisely control their length by means 
of design and only average length can be estimated. Spacer fl ex-
ibility may prevent optimal exposure of integrin ligands. 
 To study cell-ECM adhesion interactions, it is necessary to fi rst 
reduce the complexity of the research question to a well-defi ned 
model system. Diblock-copolymer micelle nanolithography 
 Figure 1.  Molecular structure of the peptides studied in this work.  1 – 5 ) Ligand peptide comprised of a  c RGD headgroup, an alkane ( 1 – 2 ) or PEG ( 3 – 5 ) 
type spacer and a thiol anchor for surface attachment.  6 – 10 ) Ligand peptide consisting of the  c RGD headgroup ligated to a polyproline spacer using 
click chemistry. The lysine linker on the opposite end is acetylated at the N α position for the attachment of monovalent compounds ( 6 – 8 ) or used 
as a branching unit for the synthesis of a peptide head-to-head dimer ( 9 – 10 ). Spacers linked to each other through the N α or N ε of the lysine linker 
possess a thiol anchor for surface attachment (gold-SH bond). 
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2-bromoethylamine hydrochloride (1.0 equiv.) and sodium 
azide (3.0 equiv.). [ 26 ] 
 Ahx and PEG-based spacer systems were synthesized using 
the same peptide coupling methodology as described for the 
synthesis of the linear RGD peptide (see above). The spacer 
was functionalized by trityl protected 3-mercaptopropionic acid 
(MPA) as a thiol anchor before being cleaved from the resin 
by hexafl uorisopropanol (HFIP) (20%/DCM). Each spacer 
(1.0 equiv.) was reacted with  c (-R(Pbf)GD(O t Bu)fK-) (1.0 equiv.) 
using HATU (1.0 equiv.) and DIEA (4.0 equiv.). Synthesis of the 
polyproline-based spacers followed a different Fmoc-based syn-
thesis strategy: The TCP resin was loaded with Fmoc-Lys(Alloc)-
OH, Fmoc was removed, the unprotected  N α was acetylated by 
acetic acid anhydride, and the allyloxycarbonyl protecting group 
(Alloc) was removed by a mixture of  tetrakis -triphenylphosphin-
palladium(0) (0.25 equiv.) and triphenylsilane (10.0 equiv.) in 
anhydrous DCM. For the synthesis of the polyproline sequence 
Fmoc-proline-OH (3.0 equiv.), (1-cyano-2-ethoxy-2-oxoethylide-
naminooxy) dimethylamino-morpholino-carbenium hexafl uoro-
phosphate (COMU, [ 27 ] 3.0 equiv.), ethyl(hydroxyimino)cyanoac-
etate (Oxyma, [ 28 ] 3.0 equiv.) and DIEA (6.0 equiv.) were used. 
The Fmoc group was removed by standard conditions and, as 
a last step, 5-hexynoic acid (3.0 equiv.) was coupled by COMU 
(3.0 equiv.) and DIEA (6.0 equiv.) to the polyproline sequence. 
To obtain divalent peptides the fi rst polyproline sequence was 
synthesized on the unprotected Lys- N α instead of the acetyla-
tion step. The spacer was cleaved from the solid support by 
HFIP (20%/DCM), ligated to  13 using CuSO 4 (1.0 equiv.) and 
sodium ascorbate (2.0 equiv.) per cyclic peptide in a  t BuOH/
H 2 O (1:1–2:1) mixture and purifi ed by RP-HPLC. [ 25,29 ] The 
C-terminal carboxylic acid on the lysine was functionalized 
by 2-(tritylthio)ethylamine  12 (1.0 equiv.), HATU (1.0 equiv.), 
1-hydroxy-7-aza-benzotriazole (HOAt, 1.0 equiv.), and DIEA 
(4.0 equiv.), as a last step. Finally, all remaining protecting 
groups were removed by trifl uoracetic acid/H 2 O/triisopropyl-
silane (95:2.5:2.5) treatment and the peptides were purifi ed by 
RP-HPLC ( Figure  3 ). 
 3 .  Results and Discussion 
 3.1 .  In Vitro Inhibition of Integrin Binding 
 A comprehensive list of all the monovalent and divalent  c RGD 
ligands and their reference numbers can be found in  Table  1 . 
different spacer systems on cell adhesion behavior, rat embryo 
fi broblasts (REF52) were plated on surfaces nanostructured 
with gold nanoparticles of 8 nm diameter with an interpar-
ticle distance of 68 nm and functionalized with the respec-
tive  c (-RGDfX-)-spacer derivatives. Immunohistochemical and 
cell dynamic studies revealed that the nature and length of 
the ligand-presenting molecule have a profound infl uence on 
cell adhesion behavior. Cells attached to substrates function-
alized with polyproline-containing peptides exhibited higher 
spreading rates and FA expression in comparison to those 
functionalized with analogous aliphatic or PEG-based peptides. 
We believe that the results presented in this study will reveal 
useful insights in the fi eld of ligand-oriented drug design and 
cell-adhesive surfaces. 
 2 .  Chemical Synthesis 
 The required building blocks—the  c RGD peptide and the 
spacer unit—were synthesized separately. All peptides were 
assembled using solid phase synthesis and Fmoc strategy. [ 24 ] 
The linear, side chain-protected sequence of the RGD peptide 
was synthesized on tritylchloride polystyrene (TCP) resin as 
support, starting with glycine to prevent racemization during 
the later cyclization step. The following permanent, orthogonal, 
side chain protections were used: 2,2,4,6,7-pentamethyldihyd-
robenzofuran-5-sulfonyl (Pbf) for Arg,  tert- butyl for Asp, benzyl 
(Bz) for Glu, and benzyloxycarbonyl (Cbz) for Lys. Amino acids 
(3.0 equiv.) were coupled stepwise with 2-(1 H -benzotriazole-
1-yl)-1,1,3,3-tetramethyluronium tetrafl uoroborate (TBTU, 3.0 
equiv.) and  N -hydroxy-benzotriazole (HOBt, 3.0 equiv.) as cou-
pling reagents and  N,N -diisopropylamine (DIEA, 6.0 equiv.) as 
a base. Cleavage from the resin by retention of the side-chain 
protecting groups occurred using a mixture of DCM/acetic 
acid/trifl uorethanol (7:2:1). Cyclization of the linear peptide was 
achieved by 2-(7-aza-1 H -benzotriazole-1-yl)-1,1,3,3-tetrameth-
yluronium hexafl uorophosphate (HATU, 2.0 equiv.), HOBT 
(2.0 equiv.), and DIEA (10 equiv.) using high dilution levels 
to favor the intramolecular reactions over intermolecular reac-
tions. Finally, hydrogenation of the Bz or Cbz group resulted in 
the partially protected cyclic peptide. The unprotected glutamic 
acid of the cyclic peptide was modifi ed by 2-azidoethylamine 
(4.0 equiv.,  11 ), HATU (1.05 equiv.), and DIEA (5.0 equiv.) 
resulting in the azido-modifi ed cyclic peptide  13 , suitable for 
azide-alkyne 1,3-dipolar cycloaddition (click chemistry) reac-
tions ( Figure  2 ). [ 25 ] 2-azidoethylamine was synthesized from 
 Figure 2.  Modifi cation of  c (-R(Pbf)GD(O t Bu)fE-) ( 13 ) for application in click chemistry reactions. a) H 2 , Pd/C, DMA, 12 h; b) 2-azidoethylamine, 
HATU, DMF, 1 h. 
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To evaluate possible differences in the integrin-binding affi nity 
between the ligands containing aliphatic, PEG, monomeric or 
dimeric polyproline spacers, all synthesized compounds were 
tested in a competitive ELISA. [ 23a , 23b ] Immobilized natural ligand 
vitronectin (Vn) and soluble integrin  α v β 3 were used. Highly 
active cyclic pentapeptide Cilengitide,  c (-RGDf Me V-) [ 10a , 10d ] was 
used as an internal control. The unmodifi ed stem compound 
 c (-RGDfK-), which has been described in literature, [ 15 ] was 
included for further comparison. 
 The integrin  α v β 3 binding affi nity of monovalent com-
pounds ( 1 – 5 ) with aliphatic ( 1 : 3.4 n m ,  2 : 13.6 n m ) or PEG 
spacers of different length ( 3 – 5 : 8.4–16.5 n m ) was less than the 
binding affi nity of the unmodifi ed peptide  c (-RGDfK-) (2.6 n m ) 
( Table  1 ). For the ligands with aliphatic or PEG spacers the 
binding affi nity additionally decreased with increasing spacer 
length. Remarkably, this was not the case for monovalent 
compounds containing polyproline spacers ( 6 – 8 ). The affi nity 
of the monovalent polyproline containing ligand towards inte-
grin  α v β 3 (2.1–2.5 n m ) was comparable to that of unmodi-
fi ed  c (-RGDfK-) (2.6 n m ). Although the shortest polyproline 
sequence we used consists of only three consecutive proline 
residues ( 6 ), the effect of polyproline as the ligand spacer was 
pronounced. In contrast to aliphatic or PEG spacers, a length-
controlled affi nity decrease of polyproline containing ligands 
was not evidenced when increasing the polyproline spacer 
length to six ( 7 ) or nine ( 8 ) proline residues ( Figure  4 ). 
 Figure 3.  Synthesis of a monomeric proline spacer compound and its ligation with  13 . a) i: 20% piperidine/NMP (Fmoc dpr.); ii: Ac 2 O, DIEA, NMP; iii: 
Pd(PPh 3 ) 4 , phenylsilane, anhydrous DCM, 1 h; iv: Fmoc-Pro-OH, COMU, Oxyma, DIEA, NMP, 1 h; (Pro coupling). b) i: repeats of Fmoc dpr (a i) and 
Pro coupling (a iv), 5-hexynoic acid, COMU, DIEA, NMP, 1h, ii 20% HFIP/DCM; c)  11 , CuSO 4 , NaAsc.,  tert .-BuOH/H 2 O, 70  ° C, 3 h; d ) Trt-cystamine, 
HATU, HOAt, DIEA, DMF, 1 h; e) TFA/TIPS/H 2 O, 1 h. 
 Table 1.  Inhibition of integrin binding to vitronectin ( α v β 3) by mono-
valent and divalent  c RGD pentapeptides using different kinds of spacer 
systems 
Reference number and peptide description IC 50 a) α v β 3 
[n m ] 
 1 c (-RGDfK-)[MPA] 3.4 ( ± 0.4) 
 2 c (-RGDfK-)[Ahx-MPA] 13.6 ( ± 2.4) 
 3 c (-RGDfK-)[Trigas-MPA] 8.4 ( ± 2.4) 
 4 c (-RGDfK-)[Hegas-MPA] 13.6 ( ± 3.6) 
 5 c (-RGDfK-)[HegasHegas-MPA] 16.5 ( ± 7.5) 
 6 Ac-K-[ c (-RGDfE-)[HexPPP]]-cta 2.4 ( ± 0.8) 
 7 Ac-K-[ c (-RGDfE-)[HexPPPPPP]]-cta 2.5 ( ± 0.4) 
 8 Ac-K-[ c (-RGDfE-)[HexPPPPPPPPP]]-cta 2.1 ( ± 0.2) 
 9 [ c (-RGDfE-)[HexPPP]] 2 K-cta 0.52 ( ± 0.04) 
 10 [ c (-RGDfE-)[HexPPPPPP]] 2 K-cta 0.17 ( ± 0.03) 
 c (-RGDfK-) b) 2.6 ( ± 0.6) 
Cilengitide c) 0.54 ( ± 0.15) 
 a) IC 50 values were derived from a competitive ELISA using immobilized Vn and 
soluble integrin  α v β 3; [ 23a , 23b ]  b) This cyclic pentapeptide was used as precursor for 
the design of  1 – 5 ; [ 15 ]  c) Cilengitide,  c (-RGDf Me V-) [ 10d ] was used as an internal refer-
ence compound for the integrin  α v β 3 ELISA assay. Ahx: 6-amino-hexanoic acid, 
cta: cystamin, Hegas: heptaethylene glycol amino acid (PEG thiol acid), Hex: 
4-(1-(2-aminoethyl)-1 H -1,2,3-triazol-4-yl)butanoic acid, MPA: mercaptopropionic 
acid, Trigas: triethylene glycol (PEG). 
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unmodifi ed cyclic peptide, and a higher activity was obtained 
only for octamers or even larger compounds. [ 17f  ] One report 
even describes a step-by-step decrease in binding affi nity from 
mono- to di- to tetra-valent compounds. [ 33 ] And, one study 
describes a reduction in the binding affi nity with increasing 
spacer length. [ 17e ] 
 In this work, we systematically investigated the impact of 
three different spacer types on the binding affi nity of a  c RGD 
ligand. We report the direct comparison of Ahx, PEG and poly-
proline spacers and found superior binding affi nity of ligands 
with spacers containing a polyproline sequence over those with 
Ahx and PEG spacers. 
 3.2 .  Cell Adhesion Experiments 
 3.2.1 .  Immunohistochemical Analysis of Cell Spreading 
and FA Assembly 
 REF52 cells were plated on  c RGD-nanopatterns to assess the 
infl uence of the different  c RGD coatings on cell adhesion 
behavior. Our approach to engineer cellular environments is 
based on self-organizing spatial positioning of patches of  c RGD 
attached to glass via a gold nanopattern. The glass substrates 
area, which is not covered by gold, is passivated against protein 
adsorption and cell interactions by a covalently immobilized 
PEG layer. Such substrates offer the highest possible spatial res-
olution with respect to the position of  c RGD patches made of a 
few single  c RGD molecules. On such biointerfaces, the regula-
tion of cellular responses is based on a biologically inert back-
ground that does not initiate any cell activation, which is then 
patterned with  c RGD in well-defi ned nanoscopic geometries. 
This approach is very powerful, since it enables the testing of 
cellular responses to individual  c RGD nanopatches and their 
spatial ordering which is very important for comparing the 
impact of different ligands for integrin activation as reported 
here. In detail, the glass coverslips were patterned with AuNPs 
of 8 nm diameter arranged in a quasi-hexagonal structure with 
an average interparticle distance of 68 nm as reported before. [ 19 ] 
Then, glass area between the AuNPs was passivated with PEG-
terminated siloxane. [ 34 ] Subsequently, AuNPs were functional-
ized with a  c RGD-based thiol ligand as given in  Table  1 . 
 In the following, the impact of the three chemically dif-
ferent spacers, the infl uence of PEG and polyproline spacer 
length, as well as the effect of divalent polyproline spacer sys-
tems on the assembly of FAs and actin fi bers were examined. 
REF52 cells were plated on the individual substrates for 4 h, 
then fi xed and stained for paxillin, nuclei and actin. Every sub-
strate induced cell adhesion and spreading, indicating suc-
cessful integrin-ligand interactions with all the different com-
pounds ( Figure  5 ). However, distinctive differences of adhesion 
based cell responses are evident between the compounds. In a 
direct comparison of compounds that differ only with respect to 
spacer length, an increase in FA density with the spacer length 
is observed (see Figure S1, Supporting Information). The same 
observation was made regarding the cell area (see Figure S2, 
Supporting Information). On all compound-coated surfaces 
 c RGD-mediated adhesion induced a dense meshwork of periph-
eral actin fi laments with only a few stress fi bers appearing. 
 The limited binding affi nity observed for aliphatic and PEG-
based spacer-containing ligands can be ascribed to their high 
fl exibility, which results in coiling and unwanted shielding of 
the pharmacophoric groups. As these spacer types are seldom 
found in a fully extended conformation (all- trans conforma-
tion), the spacer prevents maximum interaction with the inte-
grin-binding site. Obviously, the incorporation of only three 
consecutive proline residues stiffens the spacer suffi ciently to 
prevent a coiling-related negative effect on the binding affi nity 
of the peptide. 
 We explored the applicability of the polyproline spacer 
system for divalent ligands possessing two  c RGD binding 
motifs ( 9 and  10 ). The positive effect of including an extended 
polyproline sequence inside the ligand on the binding affi nity 
towards integrin  α v β 3 was confi rmed for divalent ligands. 
The extended nature of the polyproline-based dimeric con-
struct displayed, at a fi xed distance, an additional epitope 
able to promote rebinding and therefore increased the rela-
tive potency per ligand. [ 30 ] Regardless of the spacer length, 
dimerization gave compounds with sub-nanomolar activities 
( 9 : 0.52 n m ,  10 : 0.17 n m ), which is a factor of 4–14 increase 
to the activities measured for monovalent polyproline peptides 
( 6 – 8 : 2.1–2.5 n m ). Notably, these affi nities were in the range of 
the binding affi nity of Cilengitide  c (-RGDf Me V-), [ 10d ] the “gold 
standard” for targeting integrin  α v β 3. 
 Multivalent compounds fi rst appeared in literature quite 
some time ago [ 30,31 ] and the synthesis of multivalent com-
pounds using Ahx and PEG-based spacers is known. [ 17a , 17b ] 
However, previously described spacers had several disadvan-
tages. In some cases the applied spacers were very short. [ 17d , 32 ] 
In another case the addition of tetrameric compounds was 
necessary to achieve an activity comparable to that of the 
 Figure 4.  Spacer lengths (Å) and types are correlated to the integrin-
binding affi nity (IC 50 ).  1 – 2 (  ),  3 – 5 ( ),  6 – 8 ( ),  9 – 10 (). Spacer 
length was calculated for the all- trans confi guration of aliphatic (  ) and 
PEG ( ) spacers, between the C α Lys(K) and the thiol; Monomeric pro-
line ( ) spacer length was determined between the C α Glu(E) and the 
thiol; Dimeric proline () spacer length was determined between the C α 
Glu(E) via C α Lys(K) to C α Glu(E). 
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 3.2.2 .  Dynamic Analysis of Cell Adhesion and Spreading 
 As a next step, we examined the kinetics of cell adhesion and 
spreading on the differently functionalized substrates. Here, 
a homemade multiwell array with a PEG passivated and Au-
nanostructured glass base plate ( Figure  6 ) as in the case of 
immunohistochemical analysis ( Figure  5 ) was employed. The 
different wells were functionalized with the different ligands 
and cell adhesion was monitored in parallel in each of these 
wells. These studies were conducted with the rat embryo fi bro-
blast cell line REF52, which stably expresses yellow fl uores-
cent protein (YFP)-paxillin, [ 36 ] an adhesion associated protein. 
Therefore, dynamic monitoring of cell adhesion and FA forma-
tion could be achieved by fl uorescent microscopy utilizing the 
automated microscopy system Hermes Wiscan. 
 In  Figure  7 , fl uorescence optical microscopy visualization of 
YFP-paxillin REF52 shows cell spreading and FA maturation over 
time. Paxillin clusters are shown as bright, mainly elongated spots 
at the periphery of spreading cells. We have selected and presented 
in  Figure  7 micrographs sequences of cell adhesion corresponding 
to AuNP-structured surfaces functionalized with compounds  2 ,  4 , 
 6 , and  9 . These sequences adequately illustrate the overall infl uence 
of the different kinds of spacers on FA and cell adhesion dynamics. 
 A quantitative evaluation of the spreading rate was measured 
by following the projected cell area at different time points up 
to 540 min ( Figure  8 ). Isotropic growth, following a power-law 
behavior, was observed for all compounds, similar to previous 
fi ndings. [ 37 ] However, striking differences were observed with 
respect to maximum projected cell area and the time required 
to reach it. As summarized in  Table  2 , peptides bearing short 
hydrophobic spacers—compounds  1 and  2 —caused the slowest 
cellular spreading rate. Both PEG- and polyproline-containing 
(monovalent and divalent)  c RGD peptides induced faster cell-
spreading rates than those with short hydrophobic spacers. 
Noteworthy, the cellular spreading rate increased with the spacer 
length for all compounds. Remarkably, contrary to the surface 
immobilized cell assays, soluble monovalent compounds with 
alkanethiol and PEG-thiol spacers ( 1 – 5 ) showed a reduced 
affi nity to integrin with increasing spacer length in the inhibi-
tion assays ( Table  1 ). This refl ects the spacer's ability to fold and 
thereby shield the active moiety, which must be reduced by the 
interchain van der Waals’ interactions in the case of oriented 
surface immobilization in comparison to the soluble one. [ 38 ] It 
also highlights the role of ligand immobilization for cell adhe-
sion activation. Surfaces functionalized with the hydrophilic 
polyproline spacers ( 6 – 10) showed faster cell spreading char-
acteristics, which increased with extending spacer length and 
dimerization. Lag time for spreading initiation was also infl u-
enced by the nature and length of the spacers. Cells plated on 
nanopatterns coated with compounds  6 – 10 (polyproline spacers) 
and compound  5 (longest PEG-spacer) showed the initiation 
of cell fl attening and spreading between 15 and 18 min after 
plating. In contrast, compounds  3 and  4 (shorter PEG spacers) 
and compounds  1 and  2 (short hydrophobic spacers) induced 
cell fl attening around 25 and 40 min after plating, respectively. 
 3.2.3 .  Dynamic Analysis of FA Assembly 
 To further characterize cell adhesion on the nanopatterns 
coated with the different integrin-binding molecules we studied 
There is a seemingly trend that the longer (i.e. , compare  3 vs 
 5 ,  6 vs  8 , and  9 vs  10 ) and more hydrophilic the spacer is (i.e. , 
compare  2 vs  3 , and  5 vs  8 ), the more stress fi bers structures 
were formed inside the cells cytoplasm. Cells did not adhere in 
control experiments performed on passivated surfaces lacking 
 c RGD functionalization. Therefore, cell spreading and FA for-
mation is determined by the presentation of the  c RGD motif on 
the nanopatterned surface, which have strong affi nity to inte-
grin  α v β 3. [ 35 ] 
 Figure 5.  Fluorescent micrographs of representative REF52 cells on 
nanopatterns functionalized with the different monovalent and divalent 
 c RGD peptides ( 1 – 10 ). Cells were fi xed and stained for paxillin (red), 
nuclei (blue) and actin (green) after an incubation period of 4 h. 
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only 60% of the cells displayed mature FAs 60–80 min after 
seeding. Differences in the total area of mature FAs after a 
given amount of time cannot be explained only by a difference 
in how quickly spreading initiation commences. After sub-
tracting the lag time for spreading initiation from the values 
in  Figure  9 , the calculated growth rate of FAs on surfaces func-
tionalized with compounds  4 – 10 was higher than on surfaces 
functionalized with compounds containing alkane- and short 
PEG-based spacers. This can be interpreted as an increment 
of the nucleation rate on substrates with suffi ciently exposed 
ligands (vide infra). The nucleation of FAs can be described as 
the aggregation of two or more molecules of talin connecting 
two  α β -integrin dimers through actin fi laments. [ 39 ] Subsequent 
recruitment of additional components, for example, paxillin 
and vinculin, leads to the maturation of these initial clusters 
into FAs. [ 40 ] As the activity of the integrin epitope promotes the 
formation of stable integrin- c RGD complexes, it is also likely 
that high affi nity interactions between receptors and binding 
sites increase the nucleation frequency. Similar observations 
the dynamics of FA development. No signifi cant differences 
were revealed in terms of FA size and morphology for the dif-
ferent  c RGD-coated surfaces. Therefore, measurements of the 
total area of paxillin patches provided a direct quantifi cation of 
the density of FAs.  Figure  9 shows the development of the total 
area of FAs normalized by the projected area of the cell as a 
function of time. Similar to the observation on spreading ini-
tiation, FA development was signifi cantly affected by the type 
and length of the spacer. As a general rule, functionalization 
with shorter spacers led to a more delayed development of FAs. 
This was evidenced by the occurrence of paxillin patches in the 
cells in  Figure  7 . Cells on surfaces functionalized with short 
spacer compounds ( 1 – 3 ) exhibited well-defi ned FAs 2.5 h after 
seeding. On compound  1 , the development of FAs was even 
slower and only 50% of cells exhibited robust paxillin patches 
2.5 h after seeding. In contrast, nanopatterns functionalized 
with compounds containing longer spacers ( 4 – 10 ) induced FA 
development 60–80 min after cells were plated. Compounds  4 –
 10 caused similar effects, with one exception. On compound  4, 
 Figure 6.  Schematic drawing showing the steps involved in the assembly of the multiwell array employed for cell adhesion dynamics studies. AuNP 
nanopatterns, as prepared by diblock-copolymer micelle nanolithography on 26 × 76 mm N ° 1, are glued to a 16-well chamber. 1) Each well is function-
alized with a different  c RGD-based thiol ligand as given in  Table  1 . 2) YFP-paxillin REF52 cells are plated on each well and visualized with fl uorescence 
microscopy. The magnifi ed area represents the interaction between the integrin extracellular domains and the  c RGD-coated AuNP. 
 Figure 7.  Fluorescence visualization of YFP-paxillin REF52 cell adhesion dynamics on gold nanopatterned surfaces functionalized with compound  2 
( c (-RGDfK-)[Ahx-MPA]),  4 ( c (-RGDfK-)[Hegas-MPA]),  6 (Ac-K-[ c (-RGDfE-)[HexPPP]]-cta), and  9 ([ c (-RGDfE-)[HexPPP]] 2 K-cta). 
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that is,  c RGD thiol in the present case. Several studies con-
ducted on recognition-driven assembly of proteins showed that 
the binding affi nity of a protein is decreased in high-densely 
packed assemblies of the target molecule compared to those 
proteins situated on a surface with lower molecule density. [ 41 ] 
Similarly, Houseman and Mrksich observed that the activity 
of  β -1,4-galactosyltransferase was optimum when the reactant 
surface molecule (N-acetylglucosamine) constituted 70% of a 
mixed self-assembled monolayer (SAM). [ 42 ] This observation 
is attributed to steric hindrance between neighboring binding 
sites when the assembly is highly packed. Therefore, we meas-
ured the total amount of chemisorbed thiol species on planar 
gold substrates by electrochemically reductive desorption in 
alkaline solution, [ 43 ] and calculated the expected number of 
molecules per particle by assuming an available AuNP sur-
face of 50 nm 2 , which accounts to approximately 25% of the 
total area of a 8 nm-diameter AuNP, while effects of curvature 
are neglected. [ 44 ] The results are summarized in  Table  2 . The 
hydrophobic alkane ( 1 – 2 ) and more hydrophilic PEG spacers 
( 3 – 5 ) showed approximately comparative numbers of mol-
ecules per gold dot, ranging from 67 to 107. While a longer 
alkane spacer increased the number of molecules per gold 
dot from 67 to 98 ( 1 – 2 ), the number of molecules per dot was 
approximately the same for all PEG spacers of different length 
( 3 – 5 ) and in the range of the longer alkane spacer. Contrary, 
the number of monomeric polyproline-based peptides ( 6 – 8 ) 
decreased with an increase in the number of proline residues 
from 54 to 38 molecules per AuNP, respectively. Similar obser-
vations were reported in a recent study on oligoproline-based 
peptides. [ 45 ] Due to the hydrophilic nature of the polyproline 
spacer this is attributed to a reduction in the attractive 
were reported for 3T3 Swiss fi broblasts plated on thin gold 
substrates coated with a mixed SAM of  c RGDfK-terminated 
alkanethiol and tri(ethylene glycol)-terminated alkanethiol. [ 35b ] 
There, the authors showed that cells adhering to high-affi nity 
substrates had almost twice as many FAs than cells plated on 
surfaces with low-affi nity coatings. 
 Interestingly, the shape of the curves obtained for shorter 
( 1 – 3 ) and longer ( 4 – 10 ) spacers (see  Figure  9 ), showed notice-
able differences. Whereas on compounds  4 – 10 cells displayed 
a sustained increase in the total area of FAs followed by a slow 
decline towards an asymptotic value, cells plated on surfaces 
coated with compounds  1 – 3 exhibited a nearly constant value 
(meaning that FA area grew by the same proportion as cell area 
increased). The kinetics of FA assembly is obviously infl uenced 
by the quality of ligand presentation. In contrast, the density and 
distribution of paxillin-based plaques at longer time values (>6 h 
after seeding) depends on the inherent activity of the pharmaco-
phoric molecule, which in this work remained invariant. 
 Further analysis of the maximum values of the curves of FA 
expression dynamics presented in  Figure  9 revealed that cells 
adhering to nanopatterns coated with polyproline-containing 
compounds induced the highest FA expression (see  Figure S3 
in the Supporting Information). These results highlight the 
ability of polyproline-based spacers, more so than alkane and 
PEG spacers, to effi ciently present the active moiety to the cell, 
thus triggering strong integrin-ligand interactions. 
 3.2.4 .  Evaluation of the Ligand Density on AuNP 
 Activation of integrins triggered by cell-ligand interactions is 
likely to be affected by the local density of the active ligand, 
 Figure 8.  Cell spreading dynamics of YFP-paxillin as observed by  Figure  7 . Data are presented as mean  ± standard deviation. The solid lines in each 
plot represent the fi tting of the time-resolved spreading area data to a one-parameter exp4onential association function. 
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a denser packing of the monolayer. [ 38 ] It can be expected that 
the extended nature of the polyproline spacers and the reduced 
coverage density caused by the longer spacer length lead to a 
greater accessibility of individual  c RGD moieties by integrins. 
These results are in full agreement with the observed cell adhe-
sion behavior on nanopatterns functionalized with monovalent 
polyproline peptides of variable length. Longer spacers caused 
interactions between chains as the spacer length increases. This 
was also evidenced by a shift in the desorption potential to less 
negative values (see Figure S4a in the Supporting Information) 
and is probably caused by a lack of lateral hydrophobic inter-
actions among the polyproline helix, which leads to less com-
pact fi lms. This greatly differs to observations on alkanethiol 
monolayers on gold, where increasing chain length leads to 
 Figure 9.  FA expression dynamics followed by fl uorescence visualization of YFP-paxillin. Data are presented as mean  ± standard deviation. For com-
parison, FA development is visualized in  Figure  7 . 
 Table 2.  Infl uence of the spacer length and the ligand density on the spreading dynamics of YFP-paxillin REF52 cells plated on  c RGD-functionalized 
nanopatterns. 
Peptide Spacer length a) 
[Å] 
Density b) 
[molecules/50 nm 2 ] 
Time constant c) 
[s] 
 1 11 67 ( ± 5) 0.21 ( ± 0.11) 
 2 21 98 ( ± 14) 0.32 ( ± 0.05) 
 3 22 92 ( ± 6) 0.44 ( ± 0.09) 
 4 33 107 ( ± 11) 0.53 ( ± 0.14) 
 5 56 96 ( ± 10) 1.04 ( ± 0.14) 
 6 39 54 ( ± 6) 0.50 ( ± 0.08) 
 7 49 44 ( ± 6) 0.81 ( ± 0.05) 
 8 58 38 ( ± 5) 1.18 ( ± 0.12) 
 9 39 18 ( ± 4) 0.79 ( ± 0.06) 
 10 49 15 ( ± 2) 1.09 ( ± 0.08) 
 a) Spacer length was calculated for the all- trans confi guration of aliphatic and PEG spacers between C α Lys(K) and thiol, and for proline spacers between C α Glu(E) and 
thiol;  b) The surface density of the different thiol-based peptides was estimated by electrochemical reductive desorption conducted on gold planar surfaces. Values are pre-
sented as the amount of molecules per 50 nm 2 (50 nm 2 accounts to  ∼ 25% of the area of a AuNP with a 8 nm diameter), which is approximately equivalent to the available 
area on AuNPs attached to PEG-passivated surfaces; [ 54 ] c) Time constant values were obtained by fi tting the spreading data for each peptide functionalized substrate to a 
one-parameter exponential growth function. 
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of the binding motif. Because the induction of conformational 
changes in the integrin receptors [ 49 ] regulate the exposure 
of the binding site, the ligand-binding domain of the acti-
vated integrin heterodimer needs to be located at a defi ned 
minimum distance. Due to the relative shortness of the cyto-
plasmic tails of integrins, the ability to convey conformational 
changes between the integrin tail and the ligand-binding head 
group very much depends on the distance between the two. [ 50 ] 
With respect to the data presented in  Figure  8 , this reports 
that a successful binding process can only take place if the 
spacer length can span the distance between the substrate to 
which it is bound and the integrin-binding domain. To quan-
titatively assess the impact of the spacer length for each com-
pound series, we plotted the time constant values for each fi tted 
curve against the maximum spacer length ( Figure  10 ). Peptides 
containing hydrophobic ( 1 – 2 ) and PEG ( 3 – 5 ) spacers were com-
parable in their cell spreading dynamics (hydrophobic spacers: 
0.011  ± 0.016 Å −1 s −1 ; PEG spacers: 0.018  ± 0.007 Å −1 s −1 ). Pep-
tides containing polyproline spacers, in contrast, speeded up 
cell spreading. Compared to each PEG-containing peptide of 
equal length, the equivalent polyproline-containing peptides 
enhanced cell spreading by a factor of about two. Interestingly, 
monomeric and dimeric polyproline compounds presented 
similar slope values (monomers  6 – 8 : 0.036  ± 0.011 Å −1 s −1 ; 
dimers  9 – 10 : 0.032  ± 0.014 Å −1 s −1 ), but with higher spreading 
rates at equal spacer elongation in the case of the dimeric com-
pounds. These results suggest identical contribution of the 
spacer length to the spreading rate, but improved ligand avail-
ability at the nanometric scale, that is, higher integrin-binding 
affi nity, with polyproline dimers. 
a quicker activation of cell adhesion, which can be interpreted 
as a better accessibility of the ligands by the integrins. [ 46 ] QCM 
measurements performed on mixed SAMs similarly suggest 
ligand density to be important. These data show that soluble 
integrin  α v β 3 binding is indeed enhanced when the density 
of the polyproline-based  c RGD peptide is diluted with a non-
functionalized Pro 3 -SH spacer (see Figure S5, Supporting 
Information). 
 Similar properties apply for the dimeric polyproline-con-
taining compounds ( 9 – 10 ). The packing density of the mono-
layers decreases with an increasing number of proline residues 
(see Figure S4b in the Supporting Information). It should be 
noted that for the same spacer length (calculated between the 
C α Glu(E) and the thiol) the coverage density of the dimeric 
compounds was less than half of that of the monomeric coun-
terparts (i.e., compare  6 vs  9 in  Table  2 ). Therefore, the number 
of presented  c RGD moieties is also slightly lower in the case 
of the dimeric polyproline assembly. This appears reason-
able considering that two polyproline helices shared the same 
anchoring point within the dimers, resulting in even greater 
space constraints. The higher spreading rates observed for 
cells plated on nanopatterns coated with polyproline dimers 
can be ascribed to a better accessibility by integrins due to a 
less packing density and a more suitable orientation of adjacent 
 c RGD molecules towards integrin binding considering the on/
off-binding dynamics. 
 In the case of hydrophobic spacers ( 1 – 2 ) the thiolate packing 
density increased with spacer length due to enhanced attrac-
tive interactions between neighboring chains. For compound 
 2, density coverage reached values two times larger than the 
maximum value for compounds of the polyproline series (for 
details see Supporting Information, Figure S4c). The moderate 
performance of these monolayers for promoting cell adhesion 
and spreading can be attributed to the short length and high 
fl exibility of the spacers. Additionally, the close proximity of the 
bulky  c RGD molecule and the thiol group is prone to introduce 
distortions in the organic layer. This effect was stronger for 
compound  1 than for compound  2 . 
 PEG-based monolayers displayed a similar trend to that 
observed for polyproline SAMs. The reductive potential was 
shifted in a positive direction with increasing PEG chain length 
(see Figure S4d, Supporting Information), indicating a decrease 
in the attractive interactions between adjacent chains. Although 
PEG-based peptides exhibited the highest coverage of all the com-
pounds tested ( Table  2 ), the presence of all PEG chains in a fully 
extended helical brush confi guration, as is commonly observed 
for SAMs of long chain alkanethiols, is highly unlikely. [ 47 ] Under 
well-solvated conditions PEG chains adopt a highly hydrated coil 
confi guration due to the absence of the necessary driving force to 
extend their length upon surface immobilization. [ 48 ] It is there-
fore reasonable to expect some degree of coiling of molecular 
chains on PEG-based SAMs, which ultimately decreases the 
effective number of spacer molecules that are able to present the 
 c RGD binding sequence on a fully extended connector ligand. 
 3.2.5 .  Infl uence of the Spacer Length on Cell Spreading Rate 
 Integrin binding to the respective ligands depends on inte-
grin activation and is also highly sensitive to the accessibility 
 Figure 10.  Contribution of spacer length to the spreading rate of YFP-
paxillin REF52. Data are presented as mean  ± standard deviation. Time 
constant ( k ) and spacer length ( L ) values were extracted from  Table  2 . 
Slope values ( Δ k / Δ L ) were calculated by a linear fi tting for the different 
spacer series: alkane  1 – 2 ( ): 0.011  ± 0.016 Å −1 s −1 ; polyethylene glycol 
 3 – 5 (  ): 0.018  ± 0.007 Å −1 s −1 ; polyproline monomer  6 – 8 (  ): 0.036  ± 
0.011 Å −1 s −1 ; polyproline dimer  9 – 10 (  ): 0.032  ± 0.014 Å −1 s −1 . The dif-
ference between the slope obtained for polyproline spacers (monomer 
or dimer) and that obtained for polyethylene glycol spacers is signifi cant 
with 90% level of confi dence. No signifi cant ( P <0.1) difference was found 
by comparing the slopes of the alkane and polyethylene glycol series. 
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Basic 10F equipment, with a P-900 pump system, a reversed-phase 
 YMC -ODS-A C 18 column (12 nm pore size, 5  μ m particle size, 250 mm × 
4.6 mm), and UV detection (UV-900, 220 and 254 nm). The system was 
run at a fl ow rate of 1.0 mL/min over 30 min using H 2 O (0.1% TFA) and 
MeCN (0.1% TFA) as solvents. Semi-preparative HPLC was performed 
using a Waters Breeze System, including a 1525 Pump, a UV-Detector 
2487 Dual (220 and 254 nm), and the Driver Software Breeze vers. 3.20. 
As column material we used:  YMC -ODS-A C 18 (12 nm pore size, 5  μ m 
particle size, 250 mm × 20 mm),  YMC -ODS-AQ C 18 (12 nm pore size, 
5  μ m particle size, 250 mm × 20 mm) or  YMC basic (proprietary pore 
size, 5  μ m particle size, 250 mm × 20 mm). HPLC-ESI-MS analyses 
were performed on a Hewlett Packard Series HP 1100 with a Finnigan 
LCQ mass spectrometer using a  YMC -Hydrosphere C 18 column (12 nm 
pore size, 3  μ m particle size, 125 mm × 2.1 mm) or a  YMC -Octyl C 8 
column (20 nm pore size, 5  μ m particle size, 250 mm × 2.1 mm). The 
system uses H 2 O (0.1% formic acid) and MeCN (0.1% formic acid) as 
eluents. Standard peptide coupling techniques were employed. Yields 
were not optimized. All tested compounds exhibited ≥ 95% purity, as 
determined by RP-HPLC-(MS). Peptide synthesis was carried out using 
TCP resin following standard Fmoc-strategy. [ 24 ] A detailed description of 
the synthetic procedures is presented in the Supplementary Information 
section. 
 Integrin Binding Assay (Vn/ α v β 3) : The inhibiting activity of the 
integrin ligands was determined in a solid-phase binding assay using 
coated extracellular matrix protein and soluble integrin. Binding of 
the integrin was detected by a specifi c antibody in an enzyme-linked 
immune sorbent assay (ELISA). The assay was based on a previously 
reported method with several modifi cations. [ 51 ] Flat-bottom 96-well 
ELISA plates ( BRAND , Wertheim, Germany) were coated overnight at 
4  ° C with 100  μ L/well of 1.0  μ g/mL vitronectin (Millipore, Schwalbach/
Ts., Germany) in carbonate-buffer (15 m m Na 2 CO 3 , 35 m m NaHCO 3 , 
pH 9.6). Each well was then washed with PBST buffer (137 m m NaCl, 
2.7 m m KCl, 10 m m Na 2 HPO 4 , 2 m m KH 2 PO 4 , 0.01% Tween 20, pH 7.4, 
3 × 200  μ L) and blocked for 1 h at room temperature with 150  μ L/well of 
TSB-buffer (20 m m Tris-HCl, 150 m m NaCl, 1 m m CaCl 2 , 1 m m MgCl 2 , 
1 m m MnCl 2 , pH 7.5, 1% BSA). After being washed three times 
with PBST, equal volumes of internal standard (Cilengitide) or test 
compounds were mixed with 2.0  μ g/mL human integrin  α v β 3 (Millipore, 
Schwalbach/Ts., Germany). The fi nal dilution in TSB buffer was 1.0  μ g/
mL for integrin  α v β 3 and ranged between 0.00013 and 10  μ m for the 
inhibitors. The solutions (100  μ L/well) were incubated for 1 h at room 
temperature. The plate was washed three times with PBST buffer and 
100  μ L/well of 2.0  μ g/mL primary antibody mouse anti-human CD51/61 
(BD Biosciences, Heidelberg, Germany) was added to the plate. After 
incubation for 1 h at room temperature, the plate was washed three 
times with PBST. 100  μ L/well of 1.0  μ g/mL of secondary peroxidase-
labeled antibody (anti-mouse IgG-POD, Sigma-Aldrich, Taufkirchen, 
Germany) was added to the plate and incubated for 1 h at room 
temperature. After washing the plate three times with PBST, 50  μ L/well of 
SeramunBlau fast ( Seramun Diagnostic GmbH, Heidesee, Germany) was 
added and incubated for 5 min at room temperature. The reaction was 
stopped with 50  μ L/well of 3  m H 2 SO 4 and absorbance was measured at 
450 nm with a plate reader (POLARstar Galaxy, BMG Labtechnologies). 
Each compound concentration was tested in duplicate and the resulting 
inhibition curves were analyzed using OriginPro 7.5G software. In these 
measurements, the infl ection point represents the IC 50 value. Each plate 
contained Cilengitide as internal standard. 
 Biofunctionalized Nanopatterns : AuNP quasi-hexagonal patterns 
were prepared on glass coverslips by means of diblock-copolymer 
micelle nanolithography as previously described. [ 19 ] Briefl y, substrates 
were dip-coated with a solution of polystyrene(1056)-block-poly[2-
vinylpyridine(HAuCl 4 )0.25](495) (Polymer Source Inc., Canada) diblock 
copolymer micelles in  o -xylene at a constant pulling rate of 1 mm/s 
and subsequently subjected to H 2 :Ar 1:10 plasma treatment (350 W, 
0.4 mbar, 90 min). Then, substrates were treated thermally in an oven 
at 500  ° C for 48 h. This procedure provided nanopatterns consisting 
of 8 nm high AuNPs (as measured by atomic force microscopy) 
with an interparticle distance between adjacent AuNPs of 68  ± 9 nm 
 4 .  Conclusion 
 In this work we have demonstrated the advantages of using a 
polyproline sequence (rather than an Ahx or a PEG-containing 
spacer) to connect  c RGD peptides to artifi cial substrates used 
to study integrin-mediated cell adhesion. In two types of dif-
ferent experimental investigations, isolated receptor ELISA 
assays and cell adhesion studies on AuNP-structured surfaces, 
the compounds connected by the polyproline spacer resulted in 
ligands with higher integrin-binding affi nity and improved cell 
adhesion properties than ligands using spacers containing Ahx 
or PEG. In detail, ELISA assays showed that functionalization 
of the ligand using an Ahx spacer-containing peptide drastically 
decreased the ligand binding affi nity. Similarly, the applica-
tion of a PEG spacer of comparable length infl uenced ligand 
binding, however at a lesser extent than the alkyl derivative. In 
addition, increasing the length of the PEG spacer led to less 
ligand affi nity. In contrast, the use of polyproline sequences 
as  c RGD-presenting spacer did not alter the ligand binding 
affi nity towards the targeted integrin  α v β 3, independently 
of its length. Divalent ligands using the polyproline spacer 
achieved 4 to 14-fold higher ligand binding. The results of 
ELISA experiments and cell adhesion experiments were com-
parable for polyproline-based peptides. The quality of cell adhe-
sion is the lowest if a short alkyl chain or Ahx spacer is used 
and increases with an increasing length of the PEG spacer. 
More stable cell adhesion is achieved on surfaces coated with 
monovalent ligand containing a polyproline spacer. Cell adhe-
sion becomes even more mature if the proline spacer is made 
longer, and even more so when dimeric ligand peptides with 
polyproline spacers are used. Cell spreading and FA assembly 
dynamics were highly infl uenced by the type and length of 
the spacer. Again, polyproline spacers promoted stronger cell 
spreading and FA assembly compared to the other spacer types. 
These results emphasize the advantages of using a polypro-
line sequence for the backbone of ligand-presenting molecules 
instead of the commonly applied Ahx and PEG spacers. Com-
pared with alkane- and PEG-based spacers, the more extended 
characteristic of the polyproline spacers and the low-density 
assemblies they yield lead to highly accessible  c RGD moie-
ties, thus enhancing  c RGD-integrin interactions according to 
constructive cell spreading and adhesion maturation. These 
fi ndings may stimulate future development of adhesive sur-
faces with a higher affi nity and could present the possibility to 
control ligand display more precisely and constructively, thus 
enabling the study of cell adhesion processes in more defi ned 
surroundings. 
 5 .  Experimental Section 
 Chemical Synthesis : All technical solvents were distilled prior to use. 
Dry solvents were purchased from Sigma-Aldrich or Fluka. Protected 
Fmoc-amino acids and coupling reagents were purchased from Sigma-
Aldrich (Taufkirchen, Germany) Novabiochem (Schwalbach, Germany), 
Iris Biotech GmbH (Marktredwitz, Germany), PolyPeptide Laboratories 
(Strasbourg, France), and Medalchemy (Alicante, Spain). TCP-resin was 
purchased from PepChem (Tübingen, Germany). All other chemicals 
and organic solvents were purchased from commercial suppliers at the 
highest purity available and used without further purifi cation. Analytical 
HPLC was performed using the Amersham Pharmacia Biotech Äkta 
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Germany) and were subjected to reductive electrodesorption of thiols. 
The charge density of the cathodic peaks was taken as an indication of 
the surface coverage by the different  c RGD-thiol derivatives. [ 53 ] For a 
detailed description, please refer to the Supporting Information. 
 Supporting Information 
 Supporting Information is available from the Wiley Online Library or 
from the author. 
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